Planning Strategies
TECH icon

Planning Strategies’s Bio-Techne TECH Stock Holding History

Planning Strategies’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$145 Hold
2
– – ﹤0.01% 1096
2026
Q2 		$141 Buy
+2
New +$108 ﹤0.01% 1015

Other funds holding TECH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Planning Strategies's TECH Position: Q3 2026 in Review

Planning Strategies held its Bio-Techne (TECH) position steady in Q3 2026 at 2 shares worth $145. The position accounts for ﹤0.01% of the portfolio, ranked #1096.

Planning Strategies first reported a position in TECH in Q2 2026 and has held it in 2 quarters since. 451 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Planning Strategies held 2 shares of Bio-Techne worth $145 as of Q3 2026.
  • Planning Strategies left its Bio-Techne share count unchanged in Q3 2026.
  • Bio-Techne made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #1096 holding.
  • Planning Strategies first reported a position in Bio-Techne in Q2 2026 and has held it in 2 quarters since.
  • 451 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.